Literature DB >> 29995182

Gastroesophageal Reflux Disease Might Induce Certain-Supposedly Adaptive-Changes in the Esophagus: A Hypothesis.

Laura Bognár1,2, András Vereczkei3, András Papp3, Gábor Jancsó4, Örs Péter Horváth3.   

Abstract

BACKGROUND: The increasing prevalence of GERD has become a major concern due to its major health and economic impacts. Beyond the typical unpleasant symptoms, reflux can also be the source of severe, potentially life-threatening complications, such as aspiration. AIM: Our aim was to support our hypothesis that the human body may in some cases develop various protective mechanisms to prevent these conditions.
METHODS: Based on our experiences and review of the literature, we investigated the potential adaptive nature of seven reflux complications (hypertensive lower esophageal sphincter, achalasia, hypertensive upper esophageal sphincter, Zenker's diverticulum, Schatzki's ring, esophageal web, and Barrett's esophagus).
RESULTS: Patients with progressive GERD may develop diverse structural and functional esophageal changes that narrow the lumen of the esophagus and therefore reduce the risk of regurgitation and protect the upper aerodigestive tract from aspiration. The functional changes (hypertensive lower esophageal sphincter, achalasia, hypertensive upper esophageal sphincter) seem to be adaptive reactions aimed at easing the unpleasant symptoms and reducing acid regurgitation. The structural changes (Schatzki's ring, esophageal web) result in very similar outcomes, but we consider these are rather secondary consequences and not real adaptive mechanisms. Barrett's esophagus is a special form of adaptive protection. In these cases, patients report significant relief of their previous heartburn as Barrett's esophagus develops because of the replacement of the normal squamous epithelium of the esophagus by acid-resistant metaplastic epithelium.
CONCLUSION: We believe that GERD may induce different self-protective reactions in the esophagus that result in reduced acid regurgitation or decreased reflux symptoms.

Entities:  

Keywords:  Adaptive change; Aspiration; Barrett’s esophagus; Esophageal motility disorder; Gastroesophageal reflux disease

Mesh:

Year:  2018        PMID: 29995182     DOI: 10.1007/s10620-018-5184-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Gastroesophageal reflux in achalasia. When is reflux really reflux?

Authors:  P F Crookes; S Corkill; T R DeMeester
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 3.  Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention.

Authors:  X Chen; C S Yang
Journal:  Carcinogenesis       Date:  2001-08       Impact factor: 4.944

4.  Gastroesophageal reflux as a pathogenic factor in the development of symptomatic lower esophageal rings.

Authors:  J B Marshall; J M Kretschmar; A A Diaz-Arias
Journal:  Arch Intern Med       Date:  1990-08

5.  The relationship between gastro-oesophageal reflux symptoms and achalasia.

Authors:  Simon H C Anderson; Ghasem Yadegarfar; Mateen H Arastu; Roy Anggiansah; Angela Anggiansah
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-04       Impact factor: 2.566

6.  Lower esophageal ring: experiences in treatment of 88 patients.

Authors:  C E Eastridge; J W Pate; J A Mann
Journal:  Ann Thorac Surg       Date:  1984-02       Impact factor: 4.330

7.  Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual.

Authors:  D A Katzka; M Sidhu; D O Castell
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

8.  Correlation of lower esophageal mucosal ring and 24-h pH monitoring of the esophagus.

Authors:  D J Ott; M S Ledbetter; M Y Chen; J A Koufman; D W Gelfand
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

9.  Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance.

Authors:  Biljana Jovov; Christina M Van Itallie; Nicholas J Shaheen; Johnny L Carson; Todd M Gambling; James M Anderson; Roy C Orlando
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-11       Impact factor: 4.052

10.  Surgical management of hypertensive lower esophageal sphincter with dysphagia or chest pain.

Authors:  Anand P Tamhankar; Gideon Almogy; Mustafa A Arain; Giuseppe Portale; Jeffrey A Hagen; Jeffrey H Peters; Peter F Crookes; Lelan F Sillin; Steven R DeMeester; Cedric G Bremner; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  3 in total

1.  Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions.

Authors:  Katarzyna Magierowska; Dominik Bakalarz; Dagmara Wójcik; Edyta Korbut; Aleksandra Danielak; Urszula Głowacka; Robert Pajdo; Grzegorz Buszewicz; Grzegorz Ginter; Marcin Surmiak; Sławomir Kwiecień; Anna Chmura; Marcin Magierowski; Tomasz Brzozowski
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

2.  Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation.

Authors:  Andrea Oliveira Batista; Weslania Viviane Nascimento; Rachel Aguiar Cassiani; Ana Cristina Viana Silva; Leda Maria Tavares Alves; Dauana Cássia Alves; Roberto Oliveira Dantas
Journal:  Clinics (Sao Paulo)       Date:  2020-01-24       Impact factor: 2.365

3.  Esophageal Motility Disorders in the Natural History of Acid-Dependent Causes of Dysphagia and Their Influence on Patients' Quality of Life-A Prospective Cohort Study.

Authors:  Joanna Sarbinowska; Benita Wiatrak; Dorota Waśko-Czopnik
Journal:  Int J Environ Res Public Health       Date:  2021-10-23       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.